Innovations in Biotechnology applied to regenerative medicine

All candidates that have been admitted on the basis of the number of places available and their position in the ranking, are required to complete the enrolment procedure from 14 to 18 OCTOBER 2024. The procedure in question is outlined in Art. 8 of the relevant Competition Call and shall be done remotely.

Those candidates failing to complete their enrolment within the deadline set – either in the paragraph above or in the relevant ranking scrolling notices that will be published each time – will be deemed to have withdrawn. 

A non-finished merit-based ranking developed after the outcomes of the written exam that took place on October 3, 2024, is now available.

All candidates in the list are invited to sit for the second half of the exam that will consist of a self-introductory and motivation-based interview. The said examination will take place remotely on October 8, 2024, at 11:45am CEST.

To view the correction of your paper, you can access the platform at the link https://consultazioneonline.ilmiotest.it using the USERNAME (PIN) and PASSWORD provided to you on the day of the competition.

Admission tests (session 2) for the Graduate Degree Programme in Innovations in Biotechnology Applied to Regenerative Medicine (class LM-9) for the a. y. 2024/2025 will be held on 3 OCTOBER 2024 at 2:00 p.m. for candidates belonging to the quota of 25 places reserved for EU citizens wherever they reside and equivalent.

The test will be held remotely and will be computer based. The times will be indicated by e-mail to those concerned.

On the day of the test, candidates must show at the time of identification:

• A valid identification document, pursuant to art. 35 of Presidential Decree no. 445 of 28 December 2000;
• Any original documentation attesting the disability and/or SLDs declared while registering for the competition.

All candidates that have been admitted on the basis of the number of places available and their position in the ranking, are required to complete the enrolment procedure from 16 to 20 September, 2024. The procedure in question is outlined in Art. 8 of the relevant Competition Call and shall be done remotely.

Those candidates failing to complete their enrolment within the deadline set – either in the paragraph above or in the relevant ranking scrolling notices that will be published each time – will be deemed to have withdrawn. 

A non-finished merit-based ranking developed after the outcomes of the written exam that took place on September 5, 2024, is now available.

All candidates in the list are invited to sit for the second half of the exam that will consist of a self-introductory and motivation-based interview. The said examination will take place remotely on September 10, 2024, at 10:00am CEST.

To view the correction of your paper, you can access the platform at the link https://consultazioneonline.ilmiotest.it using the USERNAME (PIN) and PASSWORD provided to you on the day of the competition.

Admission tests (session 1) for the Graduate Degree Programme in Innovations in Biotechnology Applied to Regenerative Medicine (class LM-9) for the a. y. 2024/2025 will be held on 5 september 2024 at 2:00 p.m. for candidates belonging to the quota of 25 places reserved for EU citizens wherever they reside and equivalent.

The test will be held remotely and will be computer based. The times will be indicated by e-mail to those concerned.

On the day of the test, candidates must show at the time of identification:

• A valid identification document, pursuant to art. 35 of Presidential Decree no. 445 of 28 December 2000;
• Any original documentation attesting the disability and/or SLDs declared while registering for the competition.

The seats available for admission to the graduate degree programme in Innovations in Biotechnology Applied to Regenerative Medicine for the academic year 2024/2025 are:

• 25 seats for EU candidates (EU citizens residing anywhere and non-EU citizens residing in Italy);
•  5 seats for NON-EU candidates (non-EU citizens residing abroad).

In the event of dual nationality, one of which is Italian or of another EU country, this overrides the non-EU citizenship, and the candidate must apply for the EU quota of seats.

For EU and equivalent candidates, applications will be open starting from June 10, 2024.

Consult the competition call to find out the access criteria, contents and methods for administering the test. Participation in the admission test is also permitted to students who have not obtained the admission qualification, without prejudice to the obligation to obtain it by 31 December 2024.

Applicants in the NON-EU pool, reserved for non-EU citizens living abroad, should contact the International Admissions Office and comply with the respective admission procedures ( https://international.unicatt.it/ucscinternational-2-year-graduate-degrees-innovations-in-biotechnology-applied-to-regenerative-medicine).

Only for this specific category of candidates, applications will be open from 3 April to 31 May 2024.

In order to be considered eligible to take the Entrance Exam, candidates are required to submit a full application through the online system and pay the application fee at the end of the process:

• from 10 June 2024 and no later than 11:59 p.m. UTC+2 on 26 August 2024 to take part in the written test on 5 September 2024
•  from 27 August 2024 and no later than 11:59 p.m. UTC+2 on 23 September 2024 to take part in the written test on 3 October 2024

Late registrations or payments made after this deadline will not be accepted. 

For information or support with test registration, please contact:

• Toll-free number 800 954 459 (Monday to Friday from 8 a.m. to 7 p.m., Saturday from 9 a.m. to 1 p.m.)

• If you have obtained, or are going to obtain, an ITALIAN Bachelor Degree qualification (or equivalent): use the online contact form for information on Undergraduated and Integrated Degree Programmes.

• If you have obtained, or are going to obtain, a NON-ITALIAN Bachelor Degree qualification (or equivalent): please reach out to the International Admissions Office by sending an e-mail to international.admissions-rm@unicatt.it

The specific prerequisites of the Graduate Degree Programme in Innovations in Biotechnology Applied to Regenerative Medicine include knowledge of the English language demonstrated by possession of a certification at a level of not less than B2 according to the Common European Framework of Reference for Languages.

This list is exhaustive with regard to the type of certification admitted and the minimum score required: certifications not included in the list will not be taken into consideration under any circumstances. The language certificate must be produced when enrolling for the degree programme but is not required for participation in the test.

Only candidates who have conducted their entire academic studies in English before accessing the graduate degree programme may be exempted from producing the language certificate. In this case, due certification must be provided at the time of enrolment.

The Entrance Exam consists of a written test (home-based) and an oral test-interview (dual-mode) and will be held in two sessions. It is only possible to participate once - either in the first or in the second session - depending on the date of application:

FIRST SESSION:

• Written test on Thursday , September 5, 2024 at 2:00 p.m
• Oral test on Tuesday 10 September 2024 in a time slot to be determined depending on the number of participants

SECOND SESSION:

• Written test on Thursday, 3 October 2024 at 2:00 p.m.; the general convocation list will be published on 30 September 2024;
• Oral test on Tuesday 8 October 2024 in a time slot to be determined depending on the number of participants.

The written test (maximum 60 points) consists of 60 multiple-choice questions distributed as follows:

• 10 logical and logical-mathematical reasoning questions;
• 45 questions on scientific skills in the following subjects: Physiology (3), Biochemistry (4), Molecular Biology (8), Applied Biology (9), Pharmacology (3), Human Anatomy (3), Histology (3), General Pathology (3), Microbiology (3), General Chemistry (3), Organic Chemistry (3);
•  5 questions of ethical-religious culture.

The oral test-interview (maximum 60 points) is aimed at ascertaining the possession of the knowledge, skills and abilities useful for the training of a biotechnologist with expertise in innovations applied to the field of regenerative medicine through the evaluation of the type of previous study career, with specific reference to the exams taken and the type of final examination.

The oral test may be held in person (at Fondazione Poliambulanza Istituto Ospedaliero C.R.E.M. - BRESCIA) or online, at the candidate's express request (https://www.unicatt.it/richiesta-informazioni-lauree-magistrali), which must be received by the deadline indicated in the competition call.

Once the test participation fee has been paid, candidates can access the Simulator platform free of charge via their registration profile. The simulator can be used indefinitely by each registered candidate: it contains an archive of approximately 100 questions made available for practice purposes only. Questions administered on the day of the test are not extracted from the simulator.

• Instruction DIGNITAS PERSONAE on Certain Bioethical Questions
• Encyclical Letter CARITAS IN VERITATE - Pope Benedict XVI
• Encyclical Letter LAUDATO SI' - Pope Francis

Application Deadlines:

• from 10 June to 26 August 2024 at 11:59 p.m. UTC+2 for the written test on 5 September 2024;
• from 27 August to 23 September 2024 at 11:59 p.m. UTC+2 for the written test on 3 October 2024;

The same deadlines also stand valid for certifications to be submitted by candidates with a learning disorder and/or a disability, for requesting additional time and/or compensatory measures for the Exam.

Invitation to the written test (home-based):

• from 30 August 2024 for the test on 5 September 2024;
• from 30 September 2024 for the test on 3 October 2024.

Written test (home-based):

• FIRST SESSION: 5 September 2024
• SECOND SESSION: 3 October 2024

Oral test (oral mode):

• FIRST SESSION: 10 September 2024
• SECOND SESSION: 8 October 2024

Publication of written test results:

• From 7 September 2024 for the written test on 5 September 2024;
• From 7 October for the written test on 3 October 2024

Publication of final merit lists:

• From 16 September 2024 for the FIRST SESSION
• From 14 October 2024 for the SECOND SESSION

Enrolment process:

• 16 to 20 September 2024 for the FIRST SESSION
• 14 to 18 October 2024 for the SECOND SESSION

Waiting-list Calls:

• From 23 September 2024 for the first session
• From 21 October 2024 for the second session